A premium, high-yield global “casing utility” with a technical moat—now aiming to re-rate into life-science collagen via Beat’30 execution.
Overview
Viscofan is the global leader in artificial casings for the meat industry, operating 22 plants in 21 countries and serving ~1,700 customers across 100+ nations. Its products are a critical consumable “skin” enabling automated production of sausages, frankfurters, cold cuts, and meat snacks, where performance consistency is essential to avoid costly downtime. The company’s defining competitive edge is its unique ability to supply all four major casing technologies—cellulose, collagen, fibrous, and plastic—making it the only true global “One-Stop Shop.” Revenue is anchored by Traditional Business (82% of 2025 sales), complemented by a faster-growing New Business segment (13%) focused on higher-margin functional solutions, collagen health/bioengineering applications, and pet treats; Energy contributes ~5%. In 2025, Viscofan delivered record results (€1,252m revenue, +4% reported; +6.1% LFL) despite FX headwinds and collagen input inflation, and it has launched the Beat’30 plan targeting €1.8bn revenue and €450m EBITDA by 2030.